Public pressure ends 'bundled' drug program, but how much cost will drop remains unclear

JAMA. 1991 Feb 20;265(7):837-8.
No abstract available

Publication types

  • News

MeSH terms

  • Antitrust Laws
  • Clozapine*
  • Drug Industry / economics*
  • Drug Industry / legislation & jurisprudence
  • Fees, Pharmaceutical / legislation & jurisprudence
  • Humans
  • Mandatory Programs
  • Medicaid / economics
  • Mentally Ill Persons
  • Monitoring, Physiologic / economics
  • New York
  • Social Control, Formal
  • State Government
  • United States

Substances

  • Clozapine